FLORetina 2019 Florence Retina Meeting
Main Topics

Main Topics

FLORetina 2019 – Florence Retina Meeting

FLORetina 2019 covered the main topics in both surgical and medical retina, following the rule “Separate in the morning, lunch with sponsors and together in the afternoon”.

Room Verde – Friday, Saturday and Sunday morning

Medical retina specific interest

  • Retinal dystrophies: update on diagnosis and treatment
  • Inflammatory and infectious posterior uveitis: misdiagnosis and therapeutic mistakes
  • Challenging cases in macular diseases
  • Angio-OCT in multimodal imaging
  • CSC

Auditorium – Friday, Saturday and Sunday morning

Surgical retina specific interest

  • Live surgery
  • Basic and advanced vitreoretinal courses

Auditorium – Thursday, Friday and Saturday afternoon

Main topics of general interest

Diabetic macular edema

Prevention of diabetic retinopathy is now well known as a necessary condition, but it will not change the increasing burden of visual impairment from macular edema.

  • Anti-VEGF and sustained release corticosteroids: correct strategies for best results
  • Combined therapies and systemic drugs with newcomers
  • Can minimally invasive surgery be an option?
  • New lasers

Vascular retinal diseases

Pediatric retina

New trends in retinal detachment management

  • Multiple observations have underlined the role of episcleral surgery in phakic patients: is it still true in the era of 27G?
  • PVR staining is now a routine procedure in complex cases and ROSO. Endotamponades are essential tools, and new heavy liquids are facing the market.

Macular surgical diseases: new diagnostic, prognostic and therapeutic tools

New minimally invasive techniques, association with drugs and new diagnostic tools are refining our surgery. The expert panel debated personal experience and standard of treatment in macular surgical diseases.

Myopic maculopathy: medical and surgical treatments

Myopia will be a major problem for health care systems in the future, as its prevalence is increasing worldwide. Neovascular and atrophic changes, as well as traction maculopathy with foveoschisis, are partially treatable thanks to new drugs and surgery.

Dry AMD

A debate is ongoing on the role of antioxidants, and compounding evidence shows the significance of genetic testing.

  • Supplements
  • Filters and IOLs
  • Diagnosing and prognosing
  • New drugs and laser

Wet AMD

  • Trials and drugs face to face: dosing regimen, HTA evaluations
  • Intravitreal injection technique: preventing complications
  • Choosing and switching therapies
  • Is a correct diagnosis still important? Do we always choose the correct therapy?
  • New drugs

Retinal prosthesis, stem cells and genetic therapy

  • Retina: innovations, research, new tech
  • Machines and instruments
  • Submacular surgery

Imaging

  • Adaptive optics
  • Intraoperative OCT
  • New OCTs and choroidal images
  • New wavelengths to explore retinal layers
  • OCT angiography